Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Future Science OA
|
December 30, 2016
International biobanks: do or do not?
Paul N Span, Peggy Manders
Plos One
|
March 28, 2024
From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework
Jennifer E Lutomski, Peggy Manders
Biopreservation and Biobanking
|
May 27, 2021
Recommendations for a Dutch Sustainable Biobanking Environment
Rogier van der Stijl, Peggy Manders, Elisabeth W H M Eijdems
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
April 5, 2023
Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk-based Mammascreening study
Jennifer E Lutomski, Linda Rainey, Milou de Jong, et al.
Journal of Clinical Epidemiology
|
July 19, 2011
Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
Anouk Pijpe, Renée L Mulder, Peggy Manders, et al.
European Journal of Epidemiology
|
January 13, 2010
Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
Anouk Pijpe, Peggy Manders, Renée L Mulder, et al.
Journal of Clinical and Translational Research
|
March 16, 2019
Patients to learn from: on the need for systematic integration of research and care in academic health care
Martin Boeckhout, Philip Scheltens, Peggy Manders, et al.
Cancer
|
November 6, 2003
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma
Peggy Manders, Louk V A M Beex, Vivianne C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment
|
June 5, 2003
E1AF expression levels are not associated with prognosis in human breast cancer
Paul N Span, Peggy Manders, Joop J T M Heuvel, et al.
Oncogene
|
August 2, 2003
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Paul N Span, Vivianne C G Tjan-Heijnen, Peggy Manders, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Future Science OA
|
December 30, 2016
International biobanks: do or do not?
Paul N Span, Peggy Manders
Plos One
|
March 28, 2024
From opt-out to opt-in consent for secondary use of medical data and residual biomaterial: An evaluation using the RE-AIM framework
Jennifer E Lutomski, Peggy Manders
Biopreservation and Biobanking
|
May 27, 2021
Recommendations for a Dutch Sustainable Biobanking Environment
Rogier van der Stijl, Peggy Manders, Elisabeth W H M Eijdems
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
April 5, 2023
Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk-based Mammascreening study
Jennifer E Lutomski, Linda Rainey, Milou de Jong, et al.
Journal of Clinical Epidemiology
|
July 19, 2011
Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
Anouk Pijpe, Renée L Mulder, Peggy Manders, et al.
European Journal of Epidemiology
|
January 13, 2010
Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
Anouk Pijpe, Peggy Manders, Renée L Mulder, et al.
Journal of Clinical and Translational Research
|
March 16, 2019
Patients to learn from: on the need for systematic integration of research and care in academic health care
Martin Boeckhout, Philip Scheltens, Peggy Manders, et al.
Cancer
|
November 6, 2003
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma
Peggy Manders, Louk V A M Beex, Vivianne C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment
|
June 5, 2003
E1AF expression levels are not associated with prognosis in human breast cancer
Paul N Span, Peggy Manders, Joop J T M Heuvel, et al.
Oncogene
|
August 2, 2003
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Paul N Span, Vivianne C G Tjan-Heijnen, Peggy Manders, et al.
Page
of 4